PADCEV™ (enfortumab vedotin) now available in India for locally advanced or metastatic urothelial… EP News Bureau Apr 22, 2025 Enfortumab vedotin is now available for patients who received prior platinum-containing chemotherapy and a PD-1/L1 inhibitor
Gilead gets US FDA Accelerated Approval for Trodelvy to treat metastatic urothelial cancer EP News Bureau Apr 14, 2021 New indication marks secondFDAapproval for Trodelvy in 2021
